Bain Eyeing Takeover of Boots UK From Walgreens

Walgreens Boots Alliance is perhaps trying to promote its Boots pharmacies within the U.Okay., with personal fairness corporations seemingly being the recipients, a Saturday (Jan. 1) Forbes report says.

Bain Capital reportedly approached Walgreens months in the past about taking on Boots, though Walgreens didn’t touch upon the matter.

Per the report, Walgreens has additionally been different choices for its greater than 2,000 Boots pharmacies, with the corporate contemplating varied spin-off choices.

With the stories on the U.Okay. companies, Walgreens has additionally been spending billions on the corporate’s U.S. drugstore operations on the route of recent CEO Roz Brewer, with $5.2 billion lately funneled to VillageMD to enhance the doctor-staffed clinics within the U.S.

Brewer reportedly has excessive hopes for the U.S. operation and bolstering healthcare there.

“Think about a day when 45% of our Walgreens shops — of the 9,100 shops that occur to be inside 5 miles of 75% of the properties throughout the USA — the place you may stroll in and see a major care doctor that’s connected to a Walgreens drugstore,” Brewer stated in an interview final month through the Forbes Healthcare Summit.

Final month, PYMNTS additionally reported that the corporate had been contemplating promoting its Boots Alliance enterprise, which is 172 years outdated.

See additionally: Walgreens Considering Sale of Boots Alliance

Walgreens was reported to be working with Goldman Sachs on the prospect, although issues have been nonetheless in very early levels as of early December and the sale might not occur.

Boots has round 55,000 workers in its 2,200 U.Okay. shops. Whereas Boots’ valuation is presumably sitting at 10 billion kilos, it may very well be the most important U.Okay. deal for the reason that 15 billion pound Asda and J Sainsbury merger was nixed in 2019.

In response to one analyst, Boots’ worth may very well be between 10 billion and 12 billion kilos, or round $16 billion. Nonetheless, one other analyst stated the worth was round half that.